InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Greenwald Taylor C, Chief Financial Officer. Insider active across 3 companies, notably IBEX Ltd. In total, 14 filings have been published. Split: 1 buy · 2 sells. Total volume traded: €94k. Activity tracked since 1 November 2021. The latest transaction was disclosed on 31 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Greenwald Taylor C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
956 shares@ US$35.340.0071% mcap20.5% of flowCommon SharesSEC:0001513723-26-000008:1
3,307 shares0Common SharesSEC:0001513723-26-000008:0
853 shares@ US$31.600.0063% mcap11.6% of flowCommon SharesSEC:0001513723-26-000006:0
5,500 shares0Common SharesSEC:0001513723-26-000002:0
20,000 shares0Common SharesSEC:0001513723-26-000001:0
4,196 shares0Common SharesSEC:0001513723-25-000009:0
2,295 shares@ US$40.73020.019% mcap43.9% of flowCommon SharesSEC:0001513723-25-000006:0
438 shares@ US$29.130.0027% mcap6.1% of flowCommon SharesSEC:0001513723-25-000004:0
6,294 shares0Common SharesSEC:0001628280-24-047196:0
30,000 shares0Common SharesSEC:0001140361-23-056423:0
3,585 shares@ US$1.2450.3% of flowCommon StockSEC:0001131554-22-000016:0
Canonical exit: 9 Jun 2022 (T+90)
360,000 shares@ US$2.5099.5% of flowCommon StockSEC:0001131554-21-000091:0
531 sharesCommon SharesSEC:0001209191-16-098686:0
2,247 sharesCommon SharesSEC:0001209191-16-098686:1
14 of 14 declarations
About Greenwald Taylor C
Greenwald Taylor C is the Chief Financial Officer at IBEX Ltd and SYNCHRONOSS TECHNOLOGIES INC. In these roles, he is responsible for financial management, including budgeting and financial analysis. His expertise is crucial in ensuring the financial health of the companies.
